Suzanne Roosen Acting Director of the Office of Food Policy and Response (OFPR) | Official Website
Suzanne Roosen Acting Director of the Office of Food Policy and Response (OFPR) | Official Website
This is a 20% decrease from the number of companies inspected in the previous quarter, when 10 companies received 10 inspections.
Most of the companies inspected at the time were involved in the Biologics and Devices sectors. Both the Drugs and Food and Cosmetics sectors sectors tied for second most common type.
There were five companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. Three should take voluntary action to correct their management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
C. W. Bill Young VA Medical Center | Biologics | 02/03/2023 | No Action Indicated (NAI) |
Coca-Cola North America | Food and Cosmetics | 03/02/2023 | No Action Indicated (NAI) |
Edward Zbella, P. A., M.D. | Drugs | 03/03/2023 | No Action Indicated (NAI) |
Florida Fertility Institute, P. A. | Biologics | 02/02/2023 | Voluntary Action Indicated (VAI) |
Gulf Fiberoptics, Inc. | Devices | 03/23/2023 | Voluntary Action Indicated (VAI) |
N D H Medical, Inc. | Devices | 03/01/2023 | No Action Indicated (NAI) |
SteriCube, LLC | Devices | 03/17/2023 | Voluntary Action Indicated (VAI) |
VGI Medical, LLC | Biologics | 02/06/2023 | No Action Indicated (NAI) |